The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according ...
The top official in charge of food safety and nutrition at the Food and Drug Administration resigned this week, protesting ...
The FDA late Friday started reversing termination notices for some employees that were laid off, informing workers to return ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no ...
The FDA was already understaffed and behind in inspections when the Trump administration began its layoffs. Here's what you ...
ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...